ArticleOncotarget2017
Serum IL-33 level is a predictor of progression-free survival after chemotherapy.
Wenwei Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it
ArticleOncotarget2017
Wenwei Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.